Surgery Enterprise Value Over E B I T D A from 2010 to 2024
| SGRY Stock | USD 23.01 0.34 1.46% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 15.4316518 | Current Value 19.49 | Quarterly Volatility 7.40985091 |
Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery Partners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 80.6 M, Interest Expense of 148.4 M or Selling General Administrative of 80.8 M, as well as many indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.0014 or PTB Ratio of 2.12. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
Surgery | Enterprise Value Over E B I T D A |
Latest Surgery Partners' Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Surgery Partners over the last few years. It is Surgery Partners' Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgery Partners' overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Surgery Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | 18.10 | |
| Geometric Mean | 16.84 | |
| Coefficient Of Variation | 40.95 | |
| Mean Deviation | 5.03 | |
| Median | 19.02 | |
| Standard Deviation | 7.41 | |
| Sample Variance | 54.91 | |
| Range | 25.3068 | |
| R-Value | (0.34) | |
| Mean Square Error | 52.32 | |
| R-Squared | 0.12 | |
| Significance | 0.22 | |
| Slope | (0.56) | |
| Total Sum of Squares | 768.68 |
Surgery Enterprise Value Over E B I T D A History
About Surgery Partners Financial Statements
Surgery Partners investors use historical fundamental indicators, such as Surgery Partners' Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 15.43 | 19.49 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.